May 22 (Reuters) - Shares of Intercept Pharmaceuticals Inc (ICPT.O), opens new tab fell about 16% on Monday over concerns about the prospects of the company's drug to treat a type of fatty liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback